Greenberg Traurig’s Lori Cohen has the distinct honor of consistently ranking as a litigation star who also enjoys a multi-year run as one of Benchmark’s Top 250 Women in Litigation as well as one of the Top 100 Trial Lawyers in the US. Domiciled in the firm’s Atlanta office but recognized on a coast-to-coast basis for her appearance in matters of national magnitude, Cohen has wowed both peers and clients from a diverse range of industries and jurisdictions. An all-purpose trial lawyer by training and temperament, Cohen’s aptitude and gravitas has been particularly evident in the product liability capacity, where, often appearing as lead trial counsel, she has displayed an enviable streak of wins on behalf of clients in the pharmaceutical and medical device field concerning products ranging from pelvic mesh to contact lenses. Cohen is national trial counsel, coordinating counsel, and settlement counsel for all claims concerning pelvic mesh against C. R. Bard. Over the last year, she has solidified two significant victories as well as other additional dismissals in what has been described as one of the largest and most complex mass torts in history. Cohen is also a member of Novartis’ PF3.0 panel counsel program, which includes representation of subsidiaries Sandoz, Eon Labs, and Novartis Pharmaceuticals Corporation. Cohen is national counsel for Sandoz and its subsidiary Eon in the national amiodarone litigation. She also represents Bausch Health subsidiary Bausch + Lomb in product liability litigation relating to the Trulign Toric intraocular lens, a Class III medical device approved by FDA pursuant to the Premarket Approval process. In March 2020, she secured the complete dismissal of all of plaintiffs’ claims in a closely watched case in the District of Connecticut.
